Comparison of protection efficacy of toxoid and whole-cell vaccines against porcine pleuropneumonia caused by endotracheal infection with Actinobacillus pleuropneumoniae

Acta Veterinaria Brno

Volumn 72, Issue 2, 2003, Pages 213-219

  Šatrán, Petr ^a   Nedbalcova K ^b   Kucerova Z ^b  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

Lung lesions; Pig; Porcine pleuropneumonia; Tonsils; Vaccine protectivity

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIA VACCINE; APX 1 TOXIN; APX 2 TOXIN; APX 3 TOXIN; BACTERIAL VACCINE; INACTIVATED VACCINE; OUTER MEMBRANE PROTEIN; TOXIN; TOXOID VACCINE; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; INOCULATION; LUNG INJURY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PNEUMONIA; PROTECTION; REVACCINATION; SCORING SYSTEM; SEROTYPE; SURVIVAL RATE; SWINE; SYMPTOM; TONSIL; TRACHEITIS; VACCINATION;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA; SUIDAE; SUS SCROFA;

EID: 0043268158     PISSN: 00017213     EISSN: None     Source Type: Journal    
DOI: 10.2754/avb200372020213     Document Type: Article

References (12)

1. BYRD, W, KADIS, S 1992: Preparation, characterization and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants. Infect Immun 60: 3042-3051
2. FREY, J 1995: Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends in Microbiol 3: 257-261
3. HAESBROUCK, F, CHIERS, K, OVERBEKE, V, DUCATELLE, R 1997: Actinobacillus pleuropneumoniae infection in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 58: 239-249
4. HANNAN, PCT, BHOGAL, BS, FISH, JP 1982: Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci 33: 76-88
5. HENSEL, A, HUTER, V, KATINGER, A, RAZA, P, STRNISTSCHIE, C, ROESLER, U, BRAND, E, LUBITZ, W 2000: Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 18: 2945-2955
6. HIGGINS, R, LARIVIERE, S, MITTAL, KR, MARTINEAU, KR, ROUSSEAU, GP, CAMERON, J 1985: Evaluation of a killed vaccine against porcine pleuropneumonia due to Haemophilus pleuropneumoniae. Can Vet J 26: 86-89
7. CHIANG, Y, YOUNG, TF, RAPP-GABRIELSON, VJ, ROSS, RF 1991: Improved protection of swine from pleuropneumonia by vaccination with proteinase K-treated outer membrane of Actinobacillus (Haemophilus) pleuropneumoniae. Vet Microbiol 27: 49-62
8. IZANA, TJ 1991: Virulence properties of Actinobacillus pleuropneumoniae. Microbial Pathogenesis 11: 17-23
9. NIELSEN, R 1984: Haemophilus pleuropneumoniae serotypes - cross protection experiments. Nordisk Veterinaermedicin 36: 221-234
10. PAISLEY, LG, VRAA-ANDERSEN, L, DYBKAER, L, MI̧LLER, K, CHRISTENSEN, G, MOUSING, J, AGGER, JF 1993: An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. I: Prevalence of respiratory lesions at slaughter and their effects on growth. Acta Vet Scand 34: 319-329
11. RAPP, VJ, ROSS, RF 1988: Immunogenicity of outer membrane components of Haemophilus pleuropneumoniae. Can Vet J 29: 585-587
12. SEBUNYA, TNK, SAUNDERS, JR 1983: Haemophilus pleuropneumoniae infection in swine: a review. J Am Vet Med Assoc 182: 1331-1337